A Study of CRD3874-SI in People With Solid Tumors | MicrobiomeTrials← Back to trialsNCT06021626
A Study of CRD3874-SI in People With Solid Tumors
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2023-08-25Est. Completion: 2029-08
Enrollment target: 81 participants Locations- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre, New York, United States
Other microbiome trials you might be interested in
Synovial Sarcoma
The purpose of this study is to collect and store data and samples for future research to attempt to improve outcomes fo…
Philadelphia, United StatesEst. completion Jun 2028
Phyllodes Breast TumorPrognosis
Phyllodes tumor (PT) is a rare type of breast tumor made up of both connective tissue (stroma) and gland tissue (epithel…
Guangzhou, ChinaCompleted May 1, 2026
Background:
Ollier disease (OD) and Maffucci syndrome (MS) are rare disorders that increase the risk of cancers in cart…
Bethesda, United StatesEst. completion Dec 31, 2030